Cerba Research appoint AgencyUK to support their global marketing communications

AUK News
Cerba Research Global Drug Development Diagnostics

Cerba Research, one of the world’s leading central, specialty and diagnostic laboratory services companies, have appointed AgencyUK to support their marketing communications effort from 2022. The appointment follows a competitive pitch that involved a number of agencies from around the world.

Cerba Research is owned by Cerba HealthCare, a leading global player in medical diagnosis. The French group has grown on the five continents and draws on 50 years of expertise in clinical pathology to better assess the risk of diseases development, detect and diagnose diseases earlier and optimize the effectiveness of personalized medicine. Cerba Research plays a key role in this ambition to scale further as they become one of the world’s leading laboratory services companies as the industry moves ever closer to the human designer medicine model for drug discovery and development programmes.

Cerba Research has been operating for 35 years, with a global network of 450 clinical laboratories anchored in seven centres across the globe including in the Americas, Europe, Africa and Asia-Pacific regions.

Cerba Research’s expertise and track record them an attractive partner for government agencies and non-government organizations as well as pharma and biotech companies thriving to change the shape of their clinical development.

“We are delighted to be working with Cerba Research during an exciting period of growth. As they continue to scale we will help them with their brand strategy, the rollout of their marketing communications, their employer brand as well as their digital capabilities, through web, mobile app and CRM platforms. We have unique experience in the healthcare sector that has led to us doubling our pharmaceutical portfolio since 2020, and Cerba Research is another significant addition” says Sammy Mansourpour, MD AgencyUK.

“We were looking for an experienced partner that brought both creativity and technical capability and we found this in AgencyUK. They have a good reputation in the healthcare sector and have previously delivered many of the vital components needed when a company like Cerba Research is in fast growth. Their insight and guidance so far haves already started to help us shape our future strategy and we’re excited for this to continue” says Sofie Vandevyver,, Head of Business Operations and Marketing, Cerba Research.

AgencyUK has already appointed Amy Boundy as Head of Strategy previously of VML London to help lead the account. Amy joins the team bringing her experience of working with pharmaceutical and biotech organizations as well as managing clinical trial programmes for the NHS.

Amy works closely with the NIHR team to increase the numbers of research projects taking place in Primary Care.. Studies include those focused on treatments for Covid-19 in the Community, such as the Principle and Panoramic platform trials and chronic conditions such as coronary heart disease and diabetes.

“I’m fascinated by the work many biotech companies do in their search for the next therapeutic drug discovery, and this has been my passion when working for agencies and pharmaceutical companies directly. AgencyUK has a unique proposition, with a fast growing healthcare portfolio and an enviable list of global brands. I’m looking forward to joining the team and embarking on the next chapter with Cerba Research” Amy Boundy, Head of Healthcare Strategy, AgencyUK.